LMS update on AMEX listing status

    MONTREAL, March 28 /CNW Telbec/ - LMS Medical Systems Inc. (AMEX:  LMZ;
TSX:LMZ) today announced that by way of a letter dated March 22, 2007, the
American Stock Exchange advised LMS of having completed their review of LMS'
plan to regain compliance with its ongoing listing standards and that the LMS
listing was being continued pursuant to an extension. As previously disclosed,
the Company is not in compliance with Section 1003 (a)(ii) of the Company
Guide with shareholders equity of less than $4,000,000 and losses from
continuing operations and/or net losses in three out of its four most recent
fiscal years and Section 1003(a)(iii) of the Company Guide with shareholders
equity of less than $6,000,000 and losses from continuing operations and/or
net losses in its five most recent fiscal years.
    During the extension period the company must provide certain periodic
reports and information to AMEX. If the Company does not show progress
consistent with the Plan, the Exchange Staff will review the circumstances and
may immediately commence delisting proceedings. By July 8, 2008, the Company
must be in compliance with all continued listing standards. Failure to regain
compliance within the timeframes outlined above will likely result in the
Exchange Staff initiating delisting proceedings pursuant to Section 1009 of
the Company Guide.


    LMS is a leader in the application of advanced mathematical modeling and
neural networks for medical use. The LMS CALM(TM) Decision Support Suite
provides physicians, nursing staff, risk managers and hospital administrators
with clinical information systems and risk management tools designed to
improve outcomes and patient care for mothers and their infants during labor
and delivery.

    Except for historical information contained herein, the matters discussed
in this news release are forward-looking statements. Because these
forward-looking statements involve risks and uncertainties, there are
important factors that could cause actual results to differ materially from
those expressed implied by the forward-looking statements including, but
without limitation, economic conditions in general and in the healthcare
market, the demand for and market for our products in domestic and
international markets, our current dependence on the CALM product suite, the
challenges associated with developing new products and obtaining regulatory
approvals if necessary, research and development activities, the uncertainty
of acceptance of our products by the medical community, the lengthy sales
cycle for our products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by others, our
dependence on our distributors, physician training, enforceability and the
costs of enforcement of our patents, potential infringements of our patents
and the other factors set forth from time to time in the Company's filings
with the United States Securities and Exchange Commission and with the
Canadian Securities Commissions. The Company has no intention of or obligation
to update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise.

For further information:

For further information: LMS Medical Systems please contact: Yves Grou,
Chief Financial Officer, LMS Medical Systems Inc., (514) 488-3461, Ext. 238,
Fax: (514) 488-1880, yves@lmsmedical.com, www.lmsmedical.com; David Gordon,
Grant Howard, The Howard Group Inc., Toll Free: 1-888-221-0915,
info@howardgroupinc.com, www.howardgroupinc.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890